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Long-term potentiation and long-term depression are enduring changes in synaptic strength, induced by specific
patterns of synaptic activity, that have received much attention as cellular models of information storage in the
central nervous system. Work in a number of brain regions, from the spinal cord to the cerebral cortex, and in many
animal species, ranging from invertebrates to humans, has demonstrated a reliable capacity for chemical synapses to
undergo lasting changes in efficacy in response to a variety of induction protocols. In addition to their physiological
relevance, long-term potentiation and depression may have important clinical applications. A growing insight into
the molecular mechanisms underlying these processes, and technological advances in non-invasive manipulation of
brain activity, now puts us at the threshold of harnessing long-term potentiation and depression and other forms of
synaptic, cellular and circuit plasticity to manipulate synaptic strength in the human nervous system. Drugs may be
used to erase or treat pathological synaptic states and non-invasive stimulation devices may be used to artificially
induce synaptic plasticity to ameliorate conditions arising from disrupted synaptic drive. These approaches hold
promise for the treatment of a variety of neurological conditions, including neuropathic pain, epilepsy, depression,
amblyopia, tinnitus and stroke.
KEYWORDS: LTP; LTD; synaptic plasticity; STDP; TMS; IPAS; TENS; DCS; VNS.
Bliss TVP, Cooke SF. Long-term potentiation and long-term depression: a clinical perspective. Clinics. 2011;66(S1):3-17.
Received for publication on March 31, 2011; Accepted for publication on April 1, 2011
E-mail: tbliss@nimr.mrc.ac.uk
INTRODUCTION
Long-term potentiation (LTP) is a form of activity-
dependent plasticity which results in a persistent enhance-
ment of synaptic transmission. LTP has been a source of
great fascination to neuroscientists since its discovery in the
early 19709s
1 because it satisfies criteria proposed by Donald
Hebb for a synaptic memory mechanism in his influential
book ‘The Organization of Behavior’.
2 Notably, LTP is long-
lasting and input-specific (changes can be induced at one set
of synapses on a cell without affecting other synapses). The
complementary process of long-term depression (LTD), in
which the efficacy of synaptic transmission is reduced,
shares these characteristics and has also received much
attention as a candidate mnemonic process.
3,4 Whether LTP
and LTD are the actual synaptic processes underlying
learning and memory, as most neuroscientists believe, has
not yet been definitively resolved.
5,6 However, at the
molecular level, it is very clear that LTP/LTD and many
forms of memory rely upon similar molecular mechanisms.
In addition, it has been demonstrated that LTP- and LTD-
like changes in synaptic strength occur as a memory is
formed at various sets of synapses in the brain, and that
these changes can occlude the artificial induction of LTP and
can be occluded by the prior induction of LTP.
7-13 The
debate on the relevance of LTP and LTD to human memory
will in all likelihood continue until we can harness these
processes to mimic the formation of a memory without prior
experience.
14
LTP and LTD have another potentially important role in
modern neuroscience, and that is the possibility that they
may be exploited to treat disorder and disease in the human
central nervous system (CNS). A variety of neurological
conditions arise from lost or excessive synaptic drive due to
sensory deprivation during childhood, brain damage or
disease. Manipulation of synaptic strength using various
developing technologies may provide a means of normal-
izing synaptic strength and thereby ameliorating plasticity-
related disorders of the CNS. In this review we will discuss
clinical applications of LTP, LTD and related forms of
synaptic plasticity and the technologies that may allow the
erasure and induction of changes in synaptic strength in the
human CNS. As a framework for this discussion we will
first provide some background on LTP and LTD.
Features of LTP/LTD: animal studies
LTP was originally observed in vivo in the hippocampus
of anaesthetized rabbits at synapses between the medial
perforant path and granule cells of the dentate gyrus.
1 In
this study, LTP was induced using a stimulating electrode
to induce a brief high-frequency train of action potentials in
the afferent pathway, thereby ensuring coincident pre- and
post-synaptic depolarization. Recordings of the synaptic
response (the population EPSP) evoked in the population of
activated granule cells revealed a lasting enhancement
of synaptic strength following tetanic (high frequency)
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3stimulation. Subsequent studies have been almost exclu-
sively conducted on rats and mice. Later it was found that
low frequency trains of electrical stimulation (1 Hz) can
induce LTD in hippocampal and cortical pathways.
15,16
Experiments in intact animals allow for assessment of the
longevity of LTP in the hippocampus using chronically
implanted recording and stimulating electrodes.
17 Under
these conditions, and using multiple induction tetani, LTP
has been observed to last for a year in rats.
18 In vitro
preparations, however, have provided most of the insights
relating to the cellular mechanisms of synaptic plasticity.
LTP and LTD have been studied throughout the CNS but,
most commonly, at Schaffer collateral-pyramidal cell
synapses in the CA1 region of the rodent transverse
hippocampal slice.
19 This preparation has proved advanta-
geous in several ways, not least because it allows for patch-
clamp recordings to be conducted with relative ease,
thereby enabling experimental control over membrane
potential. This approach has revealed that repeated pairing
of single presynaptic stimuli (causing transmitter release)
with post-synaptic depolarization is sufficient to induce
LTP, bypassing the requirement for high frequency stimula-
tion.
20 Furthermore, the concept of spike timing-dependent
plasticity (STDP) has been developed following the impor-
tant observation in other in vitro preparations that the
timing of pre- and post-synaptic action potentials (spikes)
determines the polarity of synaptic change. Repeated
activation of a presynaptic spike followed by post-synaptic
spike, within a brief time window of approximately 50 ms,
leads to LTP, while the reverse order leads to LTD.
21,22 The
transverse slice allows for easy placement of stimulating
electrodes in clearly defined afferent fibre populations
because the dendritic and cell body subfields can be
visualized. Independent stimulation of two afferent path-
ways has revealed that neighbouring synapses can be
independently potentiated or depressed. This property of
‘input specificity’ is an important characteristic of Hebbian
LTP and LTD
4,23 (see figure 1). The same two-pathway
approach led to the discovery of another key characteristic
of LTP, associativity. LTP is associative because weakly
stimulated synapses, which would not ordinarily undergo
potentiation because insufficient postsynaptic depolariza-
tion is achieved, do so when the weak stimulation is paired
with strong, LTP-inducing, stimulation of other synapses on
the same cell.
24 As initially implied by Hebb,
2 associativity
of synaptic storage mechanisms might reflect the associative
nature of human memory. These three characteristics of
longevity, input-specificity and associativity are important,
not just because they fulfill criteria predicted of an efficient
memory mechanism, but because they provide clues as to
the molecular mechanisms underlying LTP and LTD,
mechanisms that could potentially be addressed to rectify
synaptic malfunction.
Molecular mechanisms of induction
The transverse slice has the further advantage of allowing
the rapid application and removal of pharmacological agents
in order toexamine their impact on the various phases of LTP
and LTD. In this way, the involvement of a wide range of
receptors, enzymes and other intracellular signaling
molecules in the induction, expression and maintenance of
LTP and LTD has been tested. This approach, combined with
genetic manipulations in mice to remove or express key
proteins, has permitted an extensive characterization of the
molecular underpinnings of synaptic plasticity. That LTP
requires near simultaneous pre- and post-synaptic depolar-
ization indicates the involvement of a coincidence detection
mechanism. It is now known that coincidence detection is
accomplished through the NMDA receptor (NMDAR), a
voltage-dependent subtype of glutamate receptor that allows
permeation of calcium and other cations only when two
criteria are satisfied: neurotransmitter is bound following
release of glutamate from the presynaptic terminal, and the
post-synaptic membrane is sufficiently depolarized to allow
the ejection of Mg2+ ions which, at near-resting membrane
potentials, block the ion pore of NMDARs.
25 Blockade of
NMDAR with selective antagonists, such as AP5, CPP or
MK801, prevent the induction of LTP but has no effect on its
maintenance.
26 Genetic manipulation to prevent NMDAR
expression in the CA1 pyramidal cell population also
prevents the induction of LTP, as well as the expression
of several forms of hippocampus-dependent memory.
27
Interestingly, this antagonism also blocks the induction of
hippocampal LTD,
4,28 demonstrating that the two forms of
plasticity share a common NMDAR-dependent induction
mechanism.Calcium influxthroughtheNMDARiscentralto
the induction of both LTP and LTD because intracellular
application of calcium chelators, such as BAPTA or EGTA,
prevents induction of plasticity.
28,29 Moreover, uncaging of
calcium itself can induce a form of LTP or LTD,
30 depending
ontheconcentrationofcalcium,andboth effects areoccluded
by electrically induced plasticity.
31 These are the canonical
induction mechanisms for hippocampal LTP/LTD but it is
clear that there exist at these synapses and throughout
the CNS a wide range of other forms of LTP/LTD that do
not rely upon the NMDAR, notably LTD that is induced
through activation of the metabotropic glutamate receptor
(mGluR).
32,33 In addition, the induction protocols that lead to
LTP or LTD can vary in different parts of the CNS; for
instance, pairing of pre- and post-synaptic depolarization
that would lead to LTP in the hippocampus results in LTD at
parallel fibre-Purkinje cell synapses in the cerebellar cortex.
Purkinje cells are GABAergic and therefore have an
inhibitory action on their targets; thus, LTD in this case has
a similar net effect to LTP at excitatory principal cells.
3
Expression
A wide range of calcium-detection mechanisms has been
implicated in the interface between LTP/LTD induction and
expression. Activation of enzymes, such as cyclic AMP
(cAMP)-dependent kinase (PKA) and calcium calmodulin-
dependent kinase 2 (CaMKII), is essential for induction of
the canonical NMDAR-dependent form of LTP in area CA1
of the hippocampus. Both kinases detect elevations in the
level of calcium, either directly or indirectly, and are known
to phosphorylate proteins that are involved in the expres-
sion of LTP, notably AMPA receptors (AMPAR),
34 altering
their function in ways that enhance synaptic efficacy – for
example, by increasing channel conductance.
35 Conversely,
phosphatases such as calcineurin and PP1, which are also
sensitive to calcium but at lower concentrations, can
dephosphorylate the same or different protein residues
either to reverse LTP, through a process of depotentiation,
or to induce de novo LTD, by reducing AMPAR efficacy.
36
Thus a complex interplay between the activity of kinases
and phosphatases, enzymes which can also either directly or
indirectly cross-modulate each others’ activity, determines
the polarity of synaptic plasticity.
37 Persistent activation of
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4these mechanisms initiates a cascade of signaling events that
culminate in gene expression and the production of new
proteins,
38 eventually resulting in much more robust, long-
lasting changes in synaptic strength. These protein synth-
esis-dependent mechanisms underlie the sustained expres-
sion of LTP/LTD beyond the first few hours, when the early
phase of plasticity (E-LTP and E-LTD) gives way to the late
phase (L-LTP and L-LTD). Much of the signaling from the
synapse to the nucleus that initiates novel gene transcription
is accomplished by a cAMP-dependent signaling cascade
involving PKA, mitogen activated protein kinases (MAPK)
and the transcription factor cAMP-responsive element
binding protein (CREB).
39,40 Modulatory neurotransmitters
such as dopamine (DA), noradrenaline (NA), serotonin (5-
HT) and acetylcholine (ACh), which act on their respec-
tive receptors to activate cAMP-dependent signaling in
neurons,
41-44 also play a role in regulating the longevity of
synaptic plasticity. Broadly speaking these neurotransmit-
ters serve as physiological effectors of reward, punishment,
arousal and attention, all brain-states that modulate the
longevity of memory. Once transcription has occurred the
relevant plasticity-related proteins are incorporated, by a
process that is not well understood, into just the synapses
that are undergoing change and not their neighbours. An
interesting theory of synaptic tagging,
45 which now has
considerable experimental backing,
46,47 proposes that a
molecular tag is placed at synapses undergoing input-
specific plasticity. Newly translated effector proteins are
globally expressed and the molecular tag ensures that the
relevant effectors are captured only by recently active
synapses expressing the tag. The seeming metabolic
profligacy of this system may be partially overcome by
Figure 1 - LTP and LTD: Induction protocols (A) Schematic of the rodent transverse hippocampal slice, the mostly commonly used
preparation for studying LTP, LTD and related phenomena. In the configuration shown, an extracellular recording electrode is placed
among apical dendrites of CA1 pyramidal cells, and stimulating electrodes are positioned in the Schaffer (Sch) collaterals to stimulate
two separate input pathways. (B) A transverse view of the human hippocampus showing electrode placements for stimulating and
recording in the dentate gyrus.
67 (C) Diagram showing how LTP and LTD are induced in a pathway (input 1) by high- or low-frequency
stimulation (HFS or LFS) respectively, while a second pathway acts as a control (see D,E). A related form of plasticity, known as spike
timing-dependent plasticity (STDP), can be induced by repeated pairing of presynaptic and postsynaptic firing. Depending on the
relative timing, LTP or LTD is induced (see F). (D) LTP in a two-pathway experiment in the dentate gyrus of human hippocampus.
Normalized values of the slope of the population EPSP are plotted for potentiated and control pathways. After a baseline period of test
stimulation at 1 stim/min, a brief burst of high-frequency stimulation (HFS, 100 Hz for 1 sec, arrow) is delivered. The potentiation of the
response to resumed test stimulation is present immediately after HFS, and persists for at least one hour (black circles) while the control
pathway (open squares) remains unaffected, demonstrating the input-specificity of LTP.
67 Sample field potentials are shown pre- and
post-tetanus. (E) LTD in area CA1 of rat hippocampal slices induced by low frequency stimulation (LFS, ,1 Hz) for around 15 minutes
(bar). This form of plasticity is also input-specific; only the pathway subjected to LFS is depressed (black circles) (adapted from
4). (F) The
polarity of synaptic plasticity induced by STDP protocols is determined by the relative timing of pre- and post-synaptic spiking. If an
action potential is repeatedly evoked before pre-synaptic stimulation then, provided the interval is brief enough, a depression of
synaptic strength ensues. If the order is reversed so that pre-synaptic activation precedes the post-synaptic spike, as would happen if
the synaptic input contributed to triggering an action potential, then LTP is induced (rat hippocampus, adapted from
22).
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5local translation of existing or newly transcribed mRNAs at
ribosomes positioned in the dendrites; local protein synth-
esis, triggered by a molecular tag, would drastically reduce
the number of protein molecules required to potentiate or
depress individual synapses.
48,49 The molecules that act as
tags are not yet determined but there have been some
interesting recent proposals, and there is also now a better
understanding of what the effector proteins themselves are,
as we now discuss.
Maintenance
CaMKII has also been championed as a long-term main-
tenance mechanism for LTP
37 because it can phosphorylate
itself and in this way remain autonomously active for a period
of time after the dissipation of elevated calcium. This attribute,
in principle, would allow it to act as a ‘memorase’.
50 Whether
or not CaMKII does actually maintain LTP expression for long
periods of time has been questioned.
51 Inhibitors of this kinase
appear to have little effect on already established LTP.
52
However, recent data suggests that it may remain active for
several minutes after LTP induction. This could enable the
kinase to act as a ‘tag’ for recently potentiated synapses and
allow for the synapse-specific recruitment of newly synthe-
sized proteins that participate in the maintenance of long-
lasting synaptic potentiation.
46 Another kinase, PKMf,h a s
now been recognized to act in a localized fashion to maintain
synaptic potentiation for long periods of time. This kinase, an
atypical isoform of the calcium-dependent kinase PKC, is
remarkable in that it is newly expressed after LTP induction
and remains persistently active, in part because it lacks a
regulatory domain that would put a brake on its activity in the
absence of calcium. Thus, the kinase is capable of maintaining
LTP expression at least for its own lifetime and, probably
through persistent expression and some as yet not fully
understood autoregulation, for much longerperiods.
53 Indeed,
L-LTP can be reversed at least a day after induction through
specific inhibition of this kinase in vivo.
54 It is now known that
PKMf maintainsLTPby increasing the numberofAMPARsin
the synapse, thereby keeping synaptic transmission poten-
tiated.
55 There is abundant evidence that expression of LTP
depends on persistent increases in AMPAR number in the
synapse,
56 although pre-synaptic changes in the probability of
neurotransmitter release also play a role, and in some
circumstances a dominant role, in supporting at least the early
phase ofLTP.
57-59 Theevidencefor presynaptic involvement in
the expression of LTP in the hippocampus is strong, and has
been hard to reconcile with the compelling evidence for
changes in glutamate receptor number and/or modification;
we are still some way from a unified model of LTP
expression.
60 LTD also relies on both pre and post-synaptic
expression mechanisms
61 although here too the maintenance
mechanism is not fully understood.
Finally, it is important to mention that structural changes
in the size and shape of pre- and post-synaptic specializa-
tions may mediate permanent or near-permanent changes in
synaptic efficacy. Growth may allow for an increase in the
size or number of active zones on both sides of the synapse.
Spines can increase in volume after L-LTP induction and
decrease after L-LTD induction.
62 The degree to which
structural re-organisation of synapses occurs in adult
animals is not yet clear. An intriguing participant in this
later phase of synaptic plasticity is brain-derived neuro-
trophic factor (BDNF), a substance that is newly synthesised
as a result of MAPK and CREB signaling and which may
initiate structural change at tagged synapses.
63 The role of
BDNF in synaptic plasticity is multimodal and it partici-
pates in the early phases of both LTP and LTD through co-
release with presynaptic glutamate. BDNF, initially in the
form pro-BDNF, binds to two postsynaptic receptors: the
tyrosine kinase B (TrkB) receptor, whose activation facil-
itates the induction of LTP,
64 and the P75 receptor, whose
activation results in an alteration of the subunit composition
of the NMDA receptor that promotes the subsequent
induction of LTD.
65 Thus, BDNF is a major player in
synaptic plasticity, although its action is complex (see
figure 2).
LTP and LTD in human hippocampal slices
Many of the mechanisms described above have since been
demonstrated to be crucial for LTP in hippocampal tissue
excised from humans undergoing temporal lobe surgery to
alleviate otherwise intractable epilepsy. In these slice
studies, LTP was readily induced in the temporal lobe and
at perforant path-granule cell synapses in the dentate gyrus
(see figure 1B) using induction tetani comparable to those
used in slices from mouse brain.
66,67 LTP in human tissue
could be blocked by application of the NMDAR antagonist
AP5, just as in animal models. Furthermore, artificial
elevation of cAMP through application of forskolin, which
increases adenylate cyclase activity, results in chemically-
induced LTP, a phenomenon that is well documented in
rodent hippocampal slices
68 and a principal piece of
evidence for the involvement of the cAMP-dependent
cascade in L-LTP. These studies are important for their
verification that the human brain supports an LTP-like
phenomenon, but it should be borne in mind that the tissue
may have been in a pathological state as it was taken from
individuals with an epileptic focus in the temporal lobe.
Indeed, slices taken from individuals in whom the focus
was present in the hippocampus itself produced far less LTP
than those in whom the focus was elsewhere in the temporal
lobe. It is possible that LTP was occluded in those slices
taken directly from the vicinity of an epileptic focus by
previous synaptic potentiation occurring through excessive
neural activity. In keeping with this notion, levels of
CaMKII expression were found to be significantly higher
and levels of the phosphatase PP2B significantly lower in
dentate granule cells of individuals with hippocampal
epileptic foci.
69 Thus, unsurprisingly, it is clear that LTP
can be readily induced in the human CNS and that several
molecular mechanisms are shared with rodent models. With
this in mind we can now consider whether LTP and LTD
can be harnessed for therapeutic purposes in humans (see
Table 1).
Inducing LTP and LTD-like changes in the human
CNS non-invasively
Broadly speaking there are two categories of non-invasive
approach that can be taken to induce lasting change in
neural activity in the human CNS. The first category mimics
the high- or low-frequency electrical stimulation used to
induce LTP or LTD, respectively. The second removes the
requirement for frequency-based stimulation and instead
attempts to mimic pairing or STDP-like protocols of
induction (see figure 1F and figure 3).
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6Figure 2 - LTP and LTD: Schematic of molecular mechanisms. (A) The induction of canonical forms of both LTP and LTD is triggered by
activation of the NMDA class of glutamate receptor. This ionotropic receptor detects the coincidence of presynaptic and strong
postsynaptic activity by a mechanism that involves both the binding of transmitter and depolarization-induced repulsion of the Mg
2+
ions that block its ionophore at near-resting membrane potentials. In its unblocked state Ca
2+ ions are able to permeate the channel,
gaining access to Ca
2+-dependent processes in the spine and triggering synaptic plasticity. (B)C a
2+ binds to Ca
2+/calmodulin which, in
turn activates numerous kinases and phosphatases, including CaMKII, PKC and Calcineurin (PP2B) directly and PKA and PP1 indirectly.
The balance of kinase and phosphatase activity depends on the concentration and temporal profile of the postsynaptic Ca
2+ transient
(including Ca
2+ released from intracellular stores). The Ca
2+ transient determines the polarity of the induced plasticity, with low and
prolonged Ca
2+ transients inducing LTD and brief, steeper transients inducing LTP. (C) One means by which LTP is expressed is through
phosphorylation of the AMPA receptor, an ionotropic glutamate receptor that mediates baseline chemical transmission at excitatory
synapses in the CNS. Phosphorylation by CaMKII enhances the conductance of these channels. LTD, by contrast, results, in part, from the
dephosphorylation of the AMPA receptor by phosphatases. (D) Trafficking of AMPA receptors plays a major role in the expression of
LTP and LTD by increasing or decreasing the number of receptors in the postsynaptic membrane. (E) Presynaptic mechanisms leading to
a sustained increase in the probability of transmitter release also contribute to the expression of LTP. The relative contributions of pre-
and post-synaptic mechanisms may vary at different times after induction and also across different classes of synapse. Since induction of
LTP and LTD is controlled by the post-synaptic NMDA receptor, any presynapic component of expression requires a retrograde
messenger that can signal to the pre-synaptic terminal that coincidence has occurred. Two candidates are nitric oxide (NO) and
endocannabinoids (EC). (F) A second form of LTD that has been much studied is dependent on group 1 metabotropic glutamate
receptors (mGluR). Glutamate binding to this receptor initiates a signal cascade, involving the breakdown of the membrane lipid PIP2
by phospholipase C (PLC) to the important signaling molecules IP3, which releases Ca
2+ from Ca
2+ stores (not shown) and diacylglycerol
(DAG), which leads to the activation of the calcium sensitive kinase PKC. This enzyme then phosphorylates the AMPA receptor but in
such a manner that the conductance is reduced. An offshoot is the production of NO. (G) Brain-derived neurotrophic factor (BDNF)
plays a complicated role in both LTP and LTD and contributes in different ways to short-term and long-term plasticity. (H) Longer-
lasting ‘late’ forms of LTP and LTD, persisting for more than a few hours, require the synthesis of new proteins, either through novel
gene transcription or through initiation of local translation of existing transcripts. Novel gene expression requires signaling to the
nucleus from newly potentiated or depressed synapses. A major player in this process is the cAMP-dependent signaling cascade
initiated by calcium influx and involving adenylyl cyclase (AC) and cAMP-dependent kinase (PKA), which also acts directly on the AMPA
receptor in LTP expression. Catecholaminergic modulatory input plays a major role in determining the longevity of LTP and LTD,
through interaction with AC which increases levels of cAMP and thereby activates PKA. PKA then sets in action a chain of signals that
leads to the expression of new transcripts which, in turn are translated into proteins contributing to the long-term expression of
synaptic plasticity. This signaling pathway has been a major recent target of attempts to find nootropic substances. (I) There are parallel
signaling pathways, involving mitogen activated protein kinases (MAPK), that also result in the synthesis of new proteins. However, in
this case existing transcripts are locally translated into proteins, without further requirement for nuclear signaling. The MAPK pathway
is strongly implicated in mGluR-dependent LTD. (J) One newly synthesized protein that acts as a maintenance mechanism for late LTP is
PKMf. This remarkable kinase comprises the active subunit of PKM, an isoform of PKC, that is now known to maintain the presence of
AMPA receptors inserted during LTP induction, and thereby maintain LTP. Inhibition of this kinase can erase LTP and memory many
days after induction. (K) Finally, BDNF can also play a second role in synaptic plasticity, as a newly synthesized product that alters the
structure of the synapse to enforce long-term changes in synaptic strength.
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7Repetitive Transcranial Magnetic Stimulation
(rTMS)
rTMS delivers relatively small electrical currents gener-
ated by fluctuating magnetic fields administered over the
skull using a figure-of-eight magnetic coil. In most cases it
only allows for the excitation of neural circuitry in
structures relatively close to the brain surface. For this
reason the technique has primarily been used in the
neocortex and is not a suitable substitute for the kind of
invasive deep brain stimulation (DBS) currently used to
treat Parkinson’s disease.
70 Single TMS pulses evoke event-
related potentials (ERPs) that can be recorded using scalp
recording electrodes. Importantly, delivery of a high
frequency train of rTMS pulses can induce lasting potentia-
tion of ERP amplitude and low frequency rTMS can have
the opposite effect. In primary sensory cortex, ERPs can be
generated by discrete, transient sensory stimuli within the
modality of interest. These ERPs also undergo amplitude
potentiation as a result of tetanic stimulation with rTMS.
71
rTMS is being assessed as a potential treatment for a
number of neurological disorders. Parkinson’s disease is a
common neurodegenerative disorder that results from the
specific loss of dopaminergic cells in the substantia nigra
(s.n.) leading to tremor, and impairment of movement
initiation and termination. Deep brain stimulation of
subthalamic nuclei is a well established treatment in
advanced cases of Parkinson’s disease, and can be very
effective.
72 rTMS has been suggested as an alternative, non-
invasive treatment. Although the primary locus of dysfunc-
tion in Parkinson’s is too deep for standard rTMS there are
secondary effects that can be addressed with rTMS. When
cells in the s.n. degenerate, a conspicuous beta-frequency
synchronized activity arises in primary motor cortex (M1)
that is believed to contribute to limb rigidity and akinesia.
73
In an established animal model of Parkinson’s disease, in
which primates are treated with MPTP, a substance which
selectively kills dopaminergic cells in the s.n., this
synchronization of activity in M1 occurs in addition to all
the classic motor symptoms of Parkinson’s disease. Delivery
of high-frequency rTMS (130 Hz) to M1 in these monkeys
induces a lasting amelioration of rigidity and akinesia.
74
Promisingly, rTMS has also been applied to motor cortex in
human Parkinson’s sufferers to produce significant but
short-lasting improvements in motor performance.
75 This
example illustrates the important point that, even if the
primary area of dysfunction in the CNS is not accessible to
non-invasive stimulation, secondary dysfunction in more
superficial regions can be targeted in order to ameliorate the
resulting behavioral abnormality.
76 It is worth noting,
though, that a very recently developed technology, ‘deep’
rTMS
77 may soon permit non-invasive stimulation of deep
targets such as the thalamus, basal ganglia and brainstem
nuclei without delivering dangerously large currents to
the overlying cortex. This technique, which uses a three-
dimensional magnetic coil system that surrounds the
cranium in order to generate activity at much greater
depths than the traditional figure-of-8 system, may come to
replace DBS as a non-invasive treatment for Parkinson’s
disease. It may also be of benefit in the treatment of obesity,
Alzheimer’s disease and depression.
A long standing treatment for major depression has been
electroconvulsive therapy (ECT). Although still one of
few effective treatments for this troubling disorder, it is
only used when antidepressants fail because it requires
anaesthesia and carries the risk of neural damage. One effect
of ECT may be to reduce cortical excitability and, thereby,
reverse increases in the excitability of cerebral cortex,
notably within prefrontal cortex, during treatment-resistant
depression.
78 Two explanations have been offered for
pathological increases in excitability - a persistent decrease
in inhibitory tone, or a persistent potentiation of excitatory
synapses as a result of an LTP-like process. ECT results in
the expression of several biochemical markers of LTD in
animals
79 suggesting that ECT causes induction of de novo
LTD – or depotentiation of already potentiated synapses - in
the cortex. Low frequency rTMS, thought to induce LTD-
like plasticity in humans, has been applied to the prefrontal
cortex to achieve results similar to ECT in depressive
patients.
80 rTMS may, therefore, eventually serve as a more
controlled and focused alternative to ECT, one which does
not require anaesthesia and can be used over multiple
sessions without fear of major brain damage.
The fact that low frequency rTMS can be used to reduce
cortical excitability, perhaps through LTD-like plasticity
in humans
71,81 suggests that it may also be a potential
treatment for epilepsy. Epilepsy results from hyperexcit-
ability, perhaps through excessive LTP at glutamatergic
synapses, or through other mechanisms such as increased
intrinsic excitability or reduced inhibition. Thus, LTD-like
plasticity, induced with low frequency rTMS, may provide a
means to reverse LTP at saturated synapses in order to
reduce circuit excitability. Low frequency (0.3 Hz) rTMS
was first used as a treatment for epilepsy in an open-case
study performed over a decade ago, resulting in a
significant reduction in the incidence of seizures for up to
a month after five days of treatment.
82 Subsequent double-
blind randomized trials have produced mixed results,
83,84
and it is clear that further work is required to identify more
precisely the type of epilepsies that respond to rTMS and to
optimize the parameters of stimulation in different cases.
Generalized seizures may be more responsive than focal
seizures, particularly where the focus is in deep brain
structures.
The potential of rTMS to address epileptic foci has
brought to the fore the importance of navigation. The
efficacy of rTMS can be greatly increased if it is coupled
with imaging techniques such as functional MRI (fMRI) to
map the affected area, or by systematically recording the
effects of stimulation on ERP amplitude or motor output.
85
This approach enables the tailoring of treatment to
individual cases. For disorders such as Parkinson’s disease
it is very clear which structure in the brain is the primary
site of pathology and, although there are slight individual
differences in brain shape, it is relatively straightforward to
target the region to be stimulated with DBS. In the case of
stroke, a condition in which rTMS application to primary
motor cortex holds promise as a treatment, the region of
major dysfunction must be tracked in the individual before
TMS is applied because each stroke victim has a unique
pattern of damage. Neuro-navigated TMS maps motor
evoked potentials (MEPs) and the motor threshold for
eliciting responses from the muscles of interest to optimise
TMS delivery points in individual subjects.
86,87 High
frequency rTMS can then be used to enhance motor output
in affected regions. A systematic study of the efficacy of
neuro-navigated TMS as compared to conventional stereo-
taxically-guided TMS, targeting the representation of the
dorsal interosseous muscle of the hand and evaluating the
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8impact of rTMS on reaction time and pinch force, revealed
significantly greater efficacy for navigated TMS in both
these behavioral outputs as well as in potentiating MEPs
and reducing motor threshold.
88
In summary, rTMS holds promise in the treatment of a
variety of neurological disorders, perhaps through the
induction of LTP and LTD-like plasticity. Advances in
technology, allowing reliable, safe stimulation of deep
structures and careful individual tailoring of stimulation
sites and protocols using neuro-navigated TMS, will only
expand this potential (Figure 3A).
Transcutaneous electrical nerve stimulation (TENS)
Electrical stimulation can also be delivered directly to
peripheral nerves through the skin to induce LTP-like and
LTD-like changes in central neural responsiveness. Certain
clinical conditions result from pathology just a single
synapse from the periphery and may be addressed with
TENS. Chief amongst these conditions is hyperalgesia.
Plasticity at two locations contributes to this chronic pain
condition which arises from repeated peripheral application
of a noxious stimulus to the periphery. The first occurs at
the point of nociception itself (peripheral sensitization); and
the second at the first central synapses in the pathway
within the dorsal horn of the spinal cord (central sensitiza-
tion).
89 High frequency electrical stimulation can be
delivered to nociceptive C fibres in animal preparations
90,91
to induce a lasting form of LTP within the dorsal horn.
Alternatively, LTP can be induced at these same synapses
through natural stimulation of peripheral nociceptors with
heat, the noxious chemical formalin or mechanical pinching
of the skin.
92 Some of this potentiation is homosynaptic and
confined to the stimulated nociceptive (C) fibres but there
is also a component of heterosynaptic potentiation that
enhances transmission at other, surrounding C fibres, and
may contribute to secondary hyperalgesia. In addition,
sensory (A) fibres that do not mediate nociception may also
be potentiated heterosynaptically by C fibre stimulation,
perhaps through changes in the intrinsic excitability of
common target cells in the dorsal horn. As a result there can
be a lasting sensitization of sensory nerves around the site of
injury leading to hypersensitivity to non-noxious stimuli
(allodynia).
89
Central sensitization has several molecular parallels with
LTP in the hippocampus.
93 LTP in the C fibre pathway is
both NMDAR-dependent and calcium-dependent,
94,95 and
also relies upon other molecular players such as Substance P
and the NK-1 receptor.
96 Blockade of the NMDA receptor
with the non-competitive antagonist ketamine during
surgery in humans helps to prevent central sensitization
and reduce subsequent hyperalgesia on recovery,
97 and
other NMDA receptor antagonists have similar effects,
98
Given the evidence for the involvement of LTP in
hyperalgesia, as well as other forms of peripheral and
central plasticity that increase responsiveness to peripheral
stimulation, one clinical approach is to attempt to reverse
central sensitization in the dorsal horn with low frequency
stimulation of C fibres to induce LTD, or to ameliorate
peripheral sensitization by reducing dorsal horn respon-
siveness with LTD of all afferent sensory fibres. TENS
delivered to peripheral nerves containing both A and C
fibres can be used to induce LTP or LTD in the dorsal horn.
Significantly, these forms of plasticity respectively increase
or decrease the perception of pain in human subjects,
99,100 so
that, for example, pinpricks become less painful after the
delivery of low frequency TENS. The effect of inducing LTD
is, however, complicated by the fact that, while low
frequency stimulation reduces pain sensitivity directly at
the conditioning site, it has the reverse effect of secondary
hyperalgesia at adjacent sites.
99 It is also important to note
that low frequency stimulation of C fibres, which mimics a
characteristic activity pattern after injury, can induce LTP
with similar biochemical hallmarks to that induced with
high frequency stimulation.
96 In fact, the most effective way
to induce LTD of C fibre-evoked responses in the dorsal
horn is to stimulate at a low intensity that will activate A
fibres specifically and not the C fibres themselves.
91 Thus, it
is clear that while the use of TENS holds promise for
addressing hyperalgesia, the condition is complex and is
likely to require additional treatments to ameliorate all its
various components. Nonetheless, we regard the use of
TENS to treat neuropathic pain as an exemplar for the
development of non-invasive clinical strategies based on the
induction or suppression of LTP or LTD. The fact that
peripheral stimulation can be delivered immediately affer-
ent to the targeted synapses, as well as the availability of
good animal models of hyperalgesia, emphasises the
potential for a non-invasive strategy based on TENS.
Rational drug design based on manipulating the potentiated
and/or depressed state of synapses at the first stages of
transmission in peripheral nociceptive pathways offers
another promising approach.
The application of TENS has largely been limited to
situations where stimulation of monosynaptic pathways is
possible. Potentiation or depression may occur di or tri-
synaptically but this is difficult to monitor, or to predict, as
the frequency of stimulation will change due to filtering by
afferent circuitry. Nevertheless, it is known that hyperalge-
sia is associated with changes in the brain as well as those
documented in the spinal cord. The cortex, notably
somatosensory cortex and anterior cingulate cortex (ACC),
has been a site of investigation because peripheral injury, in
the form of removal of a digit in rats, induces NMDAR-
dependent plasticity in these regions of cortex.
101,102 There
are at least three synapses between nociceptive inputs and
cortical synapses undergoing LTP-like plasticity but it may
be that chronic pain arises from a concatenation of
pathological synaptic plasticity at multiple synapses
throughout the CNS. Indeed, the delivery of high frequency
TENS, producing hypersensitivity to tactile stimulation,
does lead to a potentiation of ERPs in the cortex
100 and
delivery of low frequency stimulation with rTMS in the
cortex can lead to a temporary relief of chronic pain.
103 In a
fascinating recent study of hyperalgesia induced by periph-
eral nerve injury in mice, local inhibition in the ACC of
PKMf a key maintenance molecule for NMDAR-dependent
LTP, resulted in reversal both of LTP-like plasticity induced
in the ACC by nerve damage and reduction of hypersensi-
tivity to tactile stimuli.
104 This latter study opens up another
intriguing avenue of treatment for neurological disorders
arising from pathological LTP-like plasticity, namely the
local and selective erasure of potentiation by suppressing
the activity of PKMf. From a clinical perspective the major
problem with this approach is the fact that it would be
highly invasive if used in humans and potentially danger-
ous given the indiscriminate nature of the PKMf inhibitor in
erasing synaptic plasticity and memory. However, there
may be other means of selectively erasing LTP such
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36,105,106 a phenomenon related to but
mechanistically different from LTD. For a limited time after
induction, LTP can be reversed, or depotentiated, by low-
frequency stimulation, suggesting a potential role for TENS
or rTMS in the treatment of pathological plasticity,
particularly in cases where the patient can be brought to
treatment soon after the causative event.
Photic and auditory tetanization
A series of animal and human studies has demonstrated
that plasticity can be induced in primary sensory cortices
without electrical stimulation. Here, the electrical stimulus
is replaced by rapid sensory stimulation within the
modality of interest.
107 For example, LTP-like changes, as
measured using changes in the amplitude of one compo-
nent of the visual evoked potential (VEP), can be induced
in visual cortex using a photic tetanus (9-13 Hz) that
consists of flashing or phase-reversing visual stimuli
(for example, checkerboards or sinusoidal gratings) on a
computer monitor.
108-110 Three important criteria must be
met if the location of plasticity underlying this phenom-
enon is to be securely identified. First, potentiation should
be specific to the particular stimulus, so that the potentia-
tion is no longer expressed if the spatial frequency
109
or the orientation
108 of the stimulus is altered, consistent
with plasticity occurring in primary visual cortex, where
representations of sensory primitives such as orientation
and spatial frequency have not yet been integrated into
more complex object representations.
111 This latter obser-
vation is reminiscent of the well-documented phenomenon
of perceptual learning, in which over time subjects become
gradually more and more proficient at responding to
Figure 3 - Non-invasive methods of inducing synaptic plasticity in the human CNS. (A) Repetitive trains of transcranial magnetic
stimulation (rTMS), have been employed in several regions of the brain to induce LTP- and LTD-like changes in spontaneous neural
activity and responsiveness to stimulation. This approach is limited in the frequencies that can be attained and is restricted to surface
structures in the brain, primarily cortical, close enough to the TMS device for effective stimulation. (B) Direct transdural electrical nerve
stimulation (TENS) can be used to deliver trains of stimuli to afferent fibres and induce LTP- or LTD-like changes within the spinal cord.
(C) Work in primary sensory cortices, notably visual and auditory cortex, has revealed that repetitive sensory stimulation, either flashes
or tones, can induce lasting LTP- or LTD-like changes in event-related potentials (ERPs) recorded in these regions. (D) Approaches which
combine two of the techniques described above (A-C) can be used to induce changes in synaptic strength that often have the added
advantage of reducing the amount of stimulation required and restricting the focus of the effect. Interventional paired associative
stimulation (IPAS) mimics STDP protocols by combining rTMS with TENS, or sensory stimulation, to induce lasting changes in neural
responsiveness. Just as in STDP, the timing of the two stimuli, in this case one peripheral and one central, determines the polarity of
change. (E) As well as TMS, direct current stimulation (DCS) can be used to depolarize neurons in the cortex non-invasively. This
technique delivers a very weak current continuously over an extended period. There is some indication that DC stimulation in itself can
result in lasting changes in neural responsiveness. However, there is substantial evidence that when be combined with tetanic
stimulation, or a sensori-motor task, long-lasting changes in synaptic strength can be induced. (F) Another less temporally defined
means of modulating the effects of any direct stimulation of the brain is through the ingestion or injection of drugs. Thus far there has
not been a great deal of work on combining nootropics with sensory or direct brain stimulation but this is surely an avenue that is ripe
for exploration.
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10highly specific visual stimuli,
112 and is also consistent with
observations made in animals using photic stimulation, in
which potentiation of VEPs is both eye-specific and
orientation-specific.
113 Second, in these animal models it
is possible to intervene in the visual pathway and
substitute electrical thalamic stimulation for baseline photic
stimulation and observe potentiation of the electrically
evoked test responses after inducing potentiation using
photic stimulation.
13,114 The converse is also observed. LTP
induced in primary visual cortex of the rat using tetanic
electrical stimulation of the thalamus is also reflected in a
potentiation of the VEP.
13,115 Therefore, the plasticity
underlying VEP potentiation does not occur in the retina
or in retinothalamic pathways, but in the thalamocortical
projection. Finally, it is worth noting that induction of
similar plasticity can be prevented through local blockade
in visual cortex of AMPA receptor insertion
113 or systemic
blockade of NMDA receptors,
113,114 and expression of LTP
can be reversed with local inhibition of PKMf
13 in rodents.
Thus, mechanisms that support LTP also support potentia-
tion of VEPs with photic stimulation.
From a clinical perspective, this work may prove useful in
treating monocular amblyopia, a prevalent disorder that
affects around 1% of individuals worldwide. Amblyopia
results from a mismatch in ocular function early in life,
leading to preferential allocation of visual cortex to input
through the fully functional eye. Many of the ocular
dysfunctions that cause this disorder, such as cataracts
(lens opacity), anisometropia (mismatched lens refraction)
and strabismus (misalignment of the eyes) can be fully
repaired. However, if treatment is delayed beyond around 8
years of age in humans, as often occurs for either diagnostic
or economic reasons, the cortex will not recover normal
responsiveness to input through the previously dysfunc-
tional eye.
116 Extensive work in animals has demonstrated
that monocular deprivation through eyelid suture, which
models the causes of amblyopia in humans, results in LTD
of excitatory transmission within visual cortex.
117-119
Therefore, an obvious strategy to rescue the effects of
amblyopia is to artificially induce LTP at the same synapses.
Two treatments that have been shown to have some efficacy
in adult amblyopes are perceptual learning
120,121 and
rTMS,
122 although in general functional recovery has been
both modest and short-lived. Future studies may make use
of high frequency photic stimulation as a means of
recovering function through the amblyopic eye (Figure 3C).
It is also worth considering combinatorial approaches to
inducing LTP; peripheral sensory stimulation, combined
with central activation by rTMS, may be more fruitful in
inducing lasting plasticity.
Interventional Paired-Associative Stimulation (IPAS)
One non-invasive way to achieve an effect akin to spike
timing-dependent plasticity (STDP) in the human cortex
would be to activate afferent sensory pathways using, for
example TENS or visual stimulation, in appropriately timed
conjunction with single pulses of TMS to activate post-
synaptic neurons at the target site. This approach, known as
interventional paired associative stimulation (IPAS), uses
the amplitude of the event-related potential (ERP) to
determine the point at which peripheral stimulation initiates
synaptic release. Central stimulation can then be delivered
either before or after this delay in order to induce LTD or
LTP-like effects, respectively (Figure 3D). Note that while
IPAS, like STDP, depends on the relative timing of pre- and
post-synaptic events, the parallel is not exact, since in the
case of IPAS polysynaptic pathways are involved. One clear
advantage of IPAS over frequency-based methods is that it
avoids potential risks associated with the delivery of high-
frequency stimulation - there are reported instances of
seizure as a result of using high-frequency rTMS.
123
IPAS has been applied in both somatosensory cortex and
motor cortex, using ERPs in response to stimulation of the
median and ulnar nerves as a metric of plasticity in the
cortex. Responses of the abductor pollicis brevis (APB) and
abductor digiti minimi (ADM) muscles in the hand, to both
peripheral stimulation and single cortical TMS pulses, also
served as an assay of enhanced or decreased functional
output.
124 One beautiful aspect of the results from these
experiments is the regional specificity of the LTP/LTD-like
effects. Appropriate timing of nerve stimulation with
somatosensory cortical stimulation can lead to a specific
enhancement of ERPs driven in a small partial hand-
representation area in cortex without effect on neighbouring
representations,
125 which contrasts with a broader effect of
direct rTMS application. This specificity also holds true for
motor output as the muscle response to probe stimulation,
either peripherally or cortically, can be potentiated or
depressed by appropriate IPAS delays without effect on the
neighbouring control muscle.
126 The immediate import of
this work, from a clinical perspective, may be in addressing
focal dystonia, such as writer’s cramp, in which chronic
spasmorcramping develops inhandmuscles,preventingthe
performance of fine motor skills such as writing. It is unclear
whether this disorder arises primarily from cortical or basal
ganglia dysfunction but the responses in sufferers of writer’s
cramp to IPAS were markedly different from normal control
subjectsin that the specificity oftheeffectwaslost.Incontrast
to the effects in control subjects, targeting one muscle with
IPAS had a comparable potentiating or depressing effect on
the other, control muscle, which had not undergone IPAS.
127
Thus, a loss of specificity in cortical connectivity may
contribute to the dystonia. This example provides an
illustration of how non-invasive stimulation techniques in
humans may provide information about the aetiology of
disorders - almost as important an outcome as the develop-
ment of a treatment itself.
Direct Current Stimulation (DCS)
Another approach uses an older and more basic method
to induce plasticity. Direct current stimulation (DCS)
applies continuous weak current to a superficial region of
the brain using two electrodes fitted on the scalp surface at
carefully selected sites. Delivery of this current can have
dramatic and lasting effects on ERP amplitude. The polarity
of change is determined by the polarity of stimulation.
128
From a theoretical perspective, given the careful research
that has been conducted in animal models to determine the
optimal frequency ranges of trains of discrete electrical
pulses for inducing LTP and LTD, and the precise timing of
pulses required to induce STDP, the effects of DCS, which is
non-pulsatile, are puzzling. It has previously been demon-
strated, however, that in rats DCS produces changes in the
spontaneous firing rate of cortical neurons.
129 Thus,
plasticity induced by DCS may be the product of STDP-
like interactions between DCS-induced neural activity and
discrete stimulation, either in the form of electrical pulses in
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130 or, in humans, rTMS
131 or sensory
stimulation resulting from a subject’s participation in
particular tasks.
132,133 It is known that DCS causes the
release of BDNF and that this substance modulates the
induction of NMDAR-dependent LTP through the TrkB
receptor.
64 Moreover, a combination of DCS and low-
frequency stimulation leads to LTP in ex vivo cortical
slices.
130 Slices taken from mice that do not express BDNF,
or in which the TrkB receptor is blocked, fail to show DCS-
induced LTP. The fact that low frequencies, which would
normally induce LTD, cause LTP when paired with DCS
suggests that post-synaptic cells are in a permissive state for
LTP as a result of DCS, just as clamping cells in a
depolarized state results in low frequency-induced LTP.
134
A major application of DCS has been in enhancing motor
learning through stimulation of motor cortex, an approach
that has great promise in facilitating recovery from stroke by
promoting compensatory plasticity in spared motor cortical
tissue.
133 Interestingly, mice which do not express BDNF
have significant deficits in motor learning.
130 A common
polymorphism (Val66Met) found at a frequency of .30% in
the human population is, in animal models, associated with
a reduced BDNF concentrations in the synaptic cleft and
with impaired motor learning,
130 which suggests that a
significant minority of the population may suffer from a
mild impediment in motor skill acquisition. Remarkably,
humans possessing this polymorphism show a reduction in
motor cortical plasticity, measured using ERPs, induced by
rTMS, IPAS or DCS/rTMS applied to motor cortex.
131,135
Thus, there is some mechanistic understanding of the effects
of DCS and why it may impact LTP/LTD. DCS is a
potentially important tool for clinicians attempting to
modulate synaptic plasticity to ameliorate neurological
disorders, particularly in the motor system (Figure 3E).
Vagal nerve stimulation
Vagal nerve stimulation (VNS) is a related technique to
TENS, but is more invasive. Direct electrical stimulation
requires a minimal surgical procedure in which electrodes
are wrapped around the left vagal nerve in the neck.
136
Stimulation of the vagus causes, indirectly, widespread
release of neuromodulatory substances such as acetylcho-
line, noradrenaline and dopamine through activation of the
nucleus of the solitary tract.
137 Release of acetylcholine from
neurons originating in the nucleus basalis promotes the
induction of plasticity in the cortex.
138-141 Several studies
have shown that coincident occupation of cholinergic
receptors with stimulation of glutamatergic pathways
enhances the induction of LTP/LTD.
44,142-144 VNS serves
as a minimally invasive, and therefore clinically viable,
means of stimulating the nucleus basalis and other
brainstem structures to induce release of acetylcholine and
other neuromodulators. Thus it can be paired with sensory
stimulation, task performance or rTMS in a combinatorial
approach to maximize recuperative cortical plasticity and
enhance its longevity. A recent study used this strategy to
address the prevalent neurological condition of tinnitus. The
manifestation of this disorder is a distracting, continuously
detected tone in the absence of an external auditory
stimulus. There are a multitude of causes for tinnitus,
including dysfunction of the sensory apparatus itself.
However, it is hypothesized to result, in part, from excessive
cortical representation of a small range of sound frequencies
to which the individual has previously been heavily
over-exposed,
145 and application of rTMS to this region
has had short-lived beneficial effects.
146 Induction of
tinnitus in rats by repeated exposure to a loud auditory
stimulus in a fixed range of frequencies leads to an over-
representation
Table 1 - The potential applications of LTP/LTD-like plasticity to the treatment of neurological disorders.
Disease Underlying plasticity Potential Method References
Depression Hyper-excitability of prefrontal
cortex leading to suppression of
activity in target sites.
Low frequency rTMS in prefrontal cortex to induce
LTD-like plasticity and ameliorate hyper-excitability of
prefrontal cortex.
163
Parkinson’s disease Reduced nigral drive and resultant
loss of function in basal ganglia
and motor cortex.
High frequency rTMS in motor cortex to induce LTP-like
plasticity and ameliorate lost basal ganglia drive;
75
Schizophrenia Hyper-excitability of sensory cortex. rTMS in auditory cortex to suppress auditory hallucinations
with LTD-like plasticity.
164
Epilepsy Over-excitability of neural tissue in
epileptic focus.
Low frequency rTMS to induce LTD-like plasticity and
ameliorate hyper-excitability.
82,165
Stroke Lost motor cortical tissue. DCS in combination with motor task or rTMS to induce
BDNF release and promote LTP-like plasticity in surviving
cortical circuitry.
131,135
Chronic pain LTP-like plasticity in dorsal
horn and ACC.
TENS to induce LTD in dorsal horn; rTMS to induce LTD in
ACC; Inhibition of PKM to erase LTP in ACC.
99,103,104
Amblyopia LTD-like plasticity in primary
visual cortex.
Photic tetanus to induce LTP-like plasticity in primary visual
cortex; rTMS to primary visual cortex.
108,121,122
Tinnitus Over-representation of selected
frequencies in auditory cortex
due to LTP-like plasticity
Vagal nerve stimulation to cause neuromodulator release
coupled with auditory stimulation at lost frequencies to
win back incorrectly allocated cortical tissue.
147
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12of these frequencies in primary auditory cortex and a
consequent under-representation of the remainder of
the normal frequency range. Thus, LTD-like plasticity of
synapses in the area of over-representation and LTP-like
plasticity in the areas of under-representation could be used
to redress the balance and, potentially, treat tinnitus. This
goal has recently been accomplished in rats by pairing VNS
with auditory stimuli of the appropriate frequencies to
reverse physiological correlates in auditory cortex and
restore detection of a full range of auditory stimuli.
147 The
same approach could in principle be used to treat a range of
disorders that arise from cortical misrepresentation through
deprivation or over-exposure.
Priming
Another important feature of experience-dependent plas-
ticity that has been the subject of a great deal of basic
research is metaplasticity. This is the phenomenon whereby
the past activity of a synapse alters its susceptibility to
future plasticity. We will not describe the many forms of
metaplasticity that exist (see
148 for review) but will briefly
mention one form of metaplasticity that presents itself as an
ideal candidate for augmenting the effects of non-invasive
brain stimulation: priming of LTP. In a typical example of
priming, a brief 5 hz tetanus, which in itself does not alter
the strength of synapses, greatly enhances the magnitude
and duration of LTP induced by a standard 100 Hz tetanus
at the same synapses, provided this is delivered within 30
minutes or so of the priming tetanus.
149 It is believed that
this process results from mGluR-dependent signaling,
leading to an increase in intrinsic excitability of cells.
Subsequent induction of LTP then becomes more effective
because of the increased likelihood of action potentials and,
therefore, post-synaptic depolarization for a given synaptic
input.
150 Priming of this sort also increases the longevity of
LTP, by inducing a burst of local protein synthesis, making
new proteins available for subsequent incorporation into
synapses undergoing LTP.
151 Priming can be achieved in the
human CNS by brief application of DCS or a train of
relatively low frequency rTMS to the region of interest prior
to the induction of LTP-like plasticity with rTMS or motor
training.
152-155 These studies suggest that the exploitation of
metaplasticity may prove valuable in maximizing the
clinical effects of non-invasive stimulation techniques.
Nootropics
The presumed importance of LTP/LTD in mnemonic
processes has prompted the launch of a number of drug
discovery programs by the pharmaceutical industry aimed
at improving memory function in humans and treating
disorders of memory such as Alzheimer’s disease and other
forms of dementia. A variety of drugs, referred to as
nootropics, are under development. These range from
AMPA receptor modulators, known as AMPAkines,
156 to
drugs that increase the level of cAMP and, therefore, the
activity levels of PKA and its signaling pathway.
157
Substances that enhance the efficacy of neuromodulatory
substances such as acetylcholine are currently the major
available pharmaceutical treatments for Alzheimer’s dis-
ease
158 (for reviews of nootropics see
159,160). Note that
nootropics do not themselves induce LTP, but rather
modulate natural mnemonic processes. However, as with
priming, nootropics could be used to enhance the effects of
non-invasive LTP/LTD induction in the treatment of
disease. An illustration of this combinatorial approach
comes from recent work on erasing fear in sufferers of
acrophobia (fear of heights) by invoking the natural process
of fear extinction (see
161 for review). In these studies,
application of the nootropic D-cycloserine, a modulator of
NMDAR function, was coupled with the use of virtual
reality to mimic the experience of standing in a glass
elevator, high above a vertiginous drop.
162 The result was a
striking loss of generalized fear of heights in individuals
receiving both treatments. We can imagine extending this
approach by combining the delivery of an effective
nootropic with the delivery of rTMS, DCS, TENS, repetitive
sensory stimulation or IPAS to enhance any of the
developing therapies outlined in this review (Figure 3F).
A note of caution
In humans we can mimic the experimental protocols of
frequency-dependent LTP/LTD with rTMS or TENS, and of
spike-timing dependent plasticity with IPAS. However, apart
from the few ex vivo experiments that have been conducted in
excised human tissue, we do not have a physiological read-out
in humans that allows us to be sure that we are truly observing
synaptic plasticity. It is important to note that ERPs are not as
easily interpretable as, for example, hippocampal field poten-
tials. There are two reasons for this. First, the conditions that
give rise to synchronous synaptic currents and hence (field
EPSPs) in the hippocampus do not exist in the multilaminar
neocortex; second, ERPs are recorded at a distance and not at
the site of EPSP generation. Thus, the ERP represents a complex
of electrical events; monosynaptic EPSPs, polysynaptic EPSPs
and action potentials. As a consequence, a change in the ERP
amplitude may reflect synaptic LTP/LTD, altered inhibition or
increased intrinsic excitability of the underlying cell population.
Other assays, such as motor threshold, are even less illuminat-
ing about mechanism. There is a burgeoning body of evidence
that suggests commonalities in the molecular mechanisms of
synaptic LTP/LTD in experimental preparations and non-
invasive induced plasticity in humans. Nevertheless, we should
exercise caution in equating non-invasively induced changes in
ERP magnitude with synaptic LTP and LTD. For this reason,
examples of plasticity in the human brain described in this
review have been referred to as LTP-like or LTD-like. It will be
of great importance to show that plasticity induced non-
invasive in humans exhibits longevity, input specificity and
associativity, as these are defining features of homosynaptic
Hebbian LTP/LTD. A detailed, if still incomplete, mechanistic
understanding of these forms of plasticity has emerged from
work on animal models over the past three decades, so that a
backdrop of rational drug targets and stimulation parameters is
already available. Further work to clarify that rTMS, TENS,
IPAS and sensory tetani do indeed induce lasting Hebbian
synaptic plasticity, and, if so, to identify the synapses at which it
occurs, is required if this vast knowledge base is to be effectively
exploited for the non-invasive treatment of plasticity-related
abnormalities in the human CNS.
CONCLUSIONS
We have described a number of methods for inducing
plasticity in the human nervous system, either non-invasively
o rw i t hm i n i m a l l yi n v a s i v es u r g e r y .T E N S ,r T M S ,D C S ,I P A S ,
VNS and sensory tetanic stimulation all hold significant
promise as potential treatments for a wide range of neurolo-
gical disorders. The debate on the physiological relevance of
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the meantime, analogous processes may be harnessed as tools
to recover lost function in the nervous system and to
ameliorate the effects of pathological plasticity. These methods
could, in the future, be used to rescue deficits by directly
a d d r e s s i n gt h es i t eo fp a t h o l o g yo rb yi n d u c i n gc o m p e n s a t o r y
plasticity elsewhere. The development of stimulation strate-
gies for the non-invasive induction of plasticity in the human
CNS has been guided by basic research into LTP, LTD and
STDP and, as we have seen, common molecular mechanisms
are beginning to emerge in the human and animal literatures.
In the future, a combination of nootropic and amnestic drugs
with non-invasive stimulation techniques may emerge as the
optimal therapy for plasticity-related disorders of the human
CNS.
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